首页> 外文OA文献 >Final analysis of the randomized trial on imatinib as an adjuvant in localized gastrointestinal stromal tumors (GIST) from the EORTC Soft Tissue and Bone Sarcoma Group (STBSG), the Australasian Gastro-Intestinal Trials Group (AGITG), UNICANCER, French Sarcoma Group (FSG), Italian Sarcoma Group (ISG), and Spanish Group for Research on Sarcomas (GEIS)☆

【2h】

Final analysis of the randomized trial on imatinib as an adjuvant in localized gastrointestinal stromal tumors (GIST) from the EORTC Soft Tissue and Bone Sarcoma Group (STBSG), the Australasian Gastro-Intestinal Trials Group (AGITG), UNICANCER, French Sarcoma Group (FSG), Italian Sarcoma Group (ISG), and Spanish Group for Research on Sarcomas (GEIS)☆

机译：从EORTC软组织和骨质肉瘤组（StBSG），澳大利亚胃肠 - 试验组（Agitger），Unicancer，法国Sarcoma集团（FSG）中的随机胃肠基质肿瘤（GIST）随机试验中的临床分析。），意大利赛马赛集团（ISG），以及Spanish Group关于Sarcomas（Geis）☆

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
相似文献
相关主题

著录项

作者
P.G. Casali; A. Le Cesne; A.P. Velasco; D. Kotasek; P. Rutkowski; P. Hohenberger; E. Fumagalli; I.R. Judson; A. Italiano; H. Gelderblom; N. Penel; J.T. Hartmann; F. Duffaud; D. Goldstein; J. Martin-Broto; A. Gronchi; E. Wardelmann; S. Marréaud; J.R. Zalcberg; S. Litière; J.-Y. Blay;
展开▼
作者单位

展开▼
年度 2021
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
专利

1. Time to Definitive Failure to the First Tyrosine Kinase Inhibitor in Localized GI Stromal Tumors Treated With Imatinib As an Adjuvant: A European Organisation for Research and Treatment of Cancer Soft Tissue and Bone Sarcoma Group Intergroup Randomized Trial in Collaboration With the Australasian Gastro-Intestinal Trials Group, UNICANCER, French Sarcoma Group, Italian Sarcoma Group, and Spanish Group for Research on Sarcomas [J] . Paolo G. Casali Journal of Clinical Oncology . 2015,第36期

机译：伊马替尼作为佐剂治疗的局部胃肠道间质瘤中第一种酪氨酸激酶抑制剂确定性失败的时间：一个研究和治疗癌症软组织和骨肉瘤组的欧洲组织与澳大利亚胃肠道试验组合作进行的组间随机试验，UNICANCER，法国肉瘤小组，意大利肉瘤小组和西班牙肉瘤研究小组
2. Adjuvant treatment of GIST with imatinib: solid ground or still quicksand? A comment on behalf of the EORTC Soft Tissue and Bone Sarcoma Group, the Italian Sarcoma Group, the NCRI Sarcoma Clinical Studies Group (UK), the Japanese Study Group on GIST, the French Sarcoma Group and the Spanish Sarcoma Group (GEIS). [J] . Gronchi A, Judson I, Nishida T European journal of cancer: official journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR) . 2009,第7期

机译：伊马替尼对GIST的辅助治疗：坚实的地面还是流沙？代表EORTC软组织和骨肉瘤小组，意大利肉瘤小组，NCRI肉瘤临床研究小组（英国），日本GIST研究小组，法国肉瘤小组和西班牙肉瘤小组（GEIS）发表评论。
3. Impact of chemotherapy in uterine sarcoma (UtS): review of 13 clinical trials from the EORTC Soft Tissue and Bone Sarcoma Group (STBSG) involving advanced/metastatic UtS compared to other soft tissue sarcoma (STS) patients treated with first line chemotherapy [J] . Ray-Coquard I., Rizzo E., Blay J. Y., Gynecologic Oncology: An International Journal . 2016,第1期

机译：化疗对子宫肉瘤（UtS）的影响：与其他接受一线化疗的软组织肉瘤（STS）患者相比，EORTC软组织和骨肉瘤组（STBSG）进行的13项涉及晚期/转移性UtS的临床试验回顾
4. Object-oriented business process analysis of the cooperative soft tissue sarcoma trial of the german society for paediatric oncology and haematology (GPOH). [C] . Weber R, Knaup P, Knietitg R, MEDINFO . 2001

机译：对面向对象的业务流程分析德国儿科肿瘤学和血液学学会的合作软组织肉瘤试验。
5. Trabectedin and RAdiotherapy in Soft Tissue Sarcoma (TRASTS): Results of a Phase I Study in Myxoid Liposarcoma from Spanish (GEIS) Italian (ISG) French (FSG) Sarcoma Groups [O] . Alessandro Gronchi, Nadia Hindi, Josefina Cruz, 2019

机译：Trabectedin和软组织肉瘤中的放疗（TRASTS）：来自西班牙（GEIS）意大利（ISG）法国（FSG）肉瘤组的黏液状脂质肉瘤的I期研究结果
6. Time to definitive failure to the first tyrosine kinase inhibitor in localized GI stromal tumors treated with imatinib as an adjuvant: A European Organisation for Research and Treatment of Cancer Soft Tissue and Bone Sarcoma Group Intergroup Randomized Trial in collaboration with the Australasian Gastro-Intestinal Trials Group, UNICANCER, French Sarcoma Group, Italian Sarcoma Group, and Spanish Group for Research on Sarcomas [O] . Casali, Paolo G, Le Cesne, Axel, Velasco, Andres Poveda, 2015

机译：在伊马替尼作为佐剂治疗的局部胃肠道间质瘤中，确定第一种酪氨酸激酶抑制剂最终失效的时间：欧洲癌症软组织和骨肉瘤组的研究和治疗组织与澳大利亚胃肠道试验组合作进行了组间随机试验，UNICANCER，法国肉瘤小组，意大利肉瘤小组和西班牙肉瘤研究小组

著录项

相似文献

相关主题

期刊订阅